Similarly, in myeloproliferative neoplasms (MPNs) and lymphoma, BRD4 is implicated in the activation of inflammatory cytokine signaling and abnormal cell proliferation [72]. The gene discussed is BRD4; the disease is myeloproliferative neoplasm.